At the 2024 DIA Annual Meeting in San Diego, the pharmaceutical and healthcare industries converged on several pivotal reflecting ongoing transformations within the sector. Here are some key themes that dominated discussions: AI in Drug Development: Discussions...
In the journey of drug development, biostatistics emerges as a cornerstone, ensuring that the path from the laboratory bench to the patient's bedside is navigated with precision, efficiency, and scientific rigor. For Phase 1 Clinical Research Organizations (CROs) like...
Refer to Part 1 and Part 2 of this topic series. This blog is based off a poster presentation presented at the ASCPT 2024 annual meeting. To download a PDF version, click here. Clinical studies are, albeit well-controlled, not immune to missing data, and it is crucial...
At BioPharma Services Inc, our story isn't just about groundbreaking medical research; it's a tale of passionate individuals driven by a shared vision to make a real difference in patient lives. Founded by surgeons and led by a team of experts, BioPharma Services is...
The Rise of AI in Medical Writing for Clinical Trials Undoubtedly Artificial Intelligence (AI) and ChatGPT have been the hot topics of conversation for the past year. These technologies have become personal assistants in many aspects of our lives, helping to solve a...
The development of new drugs is a long, complex, expensive, and multidisciplinary process. Drug discovery and development takes more than 10 years, and the average cost of each new drug approved for clinical use is more than $1 billion. In addition, 90% of drug...
